Research Reports
Hospital-associated Labs to Remain Sought-after for Liver Cancer Diagnostics Finds Fact.MR
In its recent study, Fact.MR projects the global market for liver cancer diagnostics to exhibit a steady rise at 5.5% CAGR throughout the forecast period 2017 to 2022.
The fifth most prevalent cancer, liver cancer, caused 9.1% deaths among the overall population affected with cancer across the globe in 2012. Extreme aggressiveness and poor survival rate related to liver cancer has pushed this disease in becoming a crucial health issue worldwide. A slew of risk factors are associated with liver cancer including infection pertaining to hepatitis C virus (HCV), diabetes, obesity, diabetes, obesity, exposure to dietary aflatoxin, alcohol-induced cirrhosis, hepatitis B virus (HBV). With the capability of modification of these risk factors, strong prospects have been offered to lower its prevalence and mortality, by utilizing preventive strategies such as lifestyle modification, and hepatitis immunization. These factors are expected to fuel demand for liver cancer diagnostics across the globe. The liver cancer diagnostics market survey offers insights on the most pertinent aspects concerning future demand and sales trajectory.
The report on the global market for liver cancer discusses such key factors that govern the economics of liver cancer diagnostics across the globe. Some of the key influences for the growth of the global liver cancer diagnostics market include:
the rising presence of carcinogenic elements in common consumables
surging exposure to toxic substances in factories & industrial settings
lack of awareness related to causes, symptoms, and preventive measures for liver cancer
high healthcare costs, deterring liver cancer patients from seeking optimum diagnosis
Looking for Regional & Segment Analysis? Check here for a Sample:
https://www.factmr.com/connectus/sample?flag=S&rep_id=73
Takeaways from the Global Liver Cancer Diagnostics Market
In terms of revenues, North America will remain the most lucrative region in the global market for liver cancer diagnostics. In addition, liver cancer diagnostics markets in North America and Europe will exhibit expansion at similar CAGRs through 2022.
Liver cancer diagnostics markets in Japan and MEA will exhibit a sluggish growth during the forecast period.
Biopsy tests will continue to exhibit the highest CAGR through 2022, among test type in the global market, followed by LFTs.
AFP test is projected to remain sought-after for liver cancer diagnostics over the forecast period. Revenues from AFP tests are estimated to hold more than half market share in 2017, and are expected to attain 52 BPS in their market share by 2022-end.
Hospital-associated labs are expected to remain sought-after in the market for liver cancer diagnostics. Liver cancer diagnostics in the hospital-associated labs are expected to account for largest revenues during the forecast period.
Independent diagnostic laboratories will continue to be the second most lucrative segment among end-users in the global market for liver cancer diagnostics.
Diagnosis of liver cancer in cancer research institutes will continue to register the highest CAGR over the forecast period.
Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=73
Market Taxonomy
Test Type
AFP Tests
LFTs
Biopsy
Other
End User
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Key Country-wise Inclusions
• US Liver Cancer Diagnostics Market
• Canada Liver Cancer Diagnostics Sales
• Germany Liver Cancer Diagnostics Production
• UK Liver Cancer Diagnostics Industry
• France Liver Cancer Diagnostics Market
• Japan Liver Cancer Diagnostics Supply Assessment
Explore All Opportunities of Liver Cancer Diagnostics Industry:
https://www.factmr.com/checkout/73
Key Market Players Mentioned in Fact.MR’s report on the Global Liver Cancer Diagnostics Market
Sysmex Corporation
Danaher Corporation
BioceptInc.
Foundation Medicine Inc
Montaplast GmbH
Valeo S.A.
SL Corporation
Explore Fact.MR’s Coverage on the Healthcare Domain
Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.
Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.
Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: [email protected]
Website: https://www.factmr.com
The post Hospital-associated Labs to Remain Sought-after for Liver Cancer Diagnostics Finds Fact.MR appeared first on TOP NEWS PRESS.
-
Top Stories3 days ago
After VW plant victory, UAW sets its sights on Mercedes in Alabama
-
Business3 days ago
Mike Bahun and Fundraising University Make a Lasting Impact on Sports Programs Nationwide
-
Investing3 days ago
Forex Market Trends to Watch Out For in 2024
-
Top Stories3 days ago
Hedge fund borrowing hits five-year peak, Goldman Sachs says